190 related articles for article (PubMed ID: 33382768)
1. HIV treatment cascade among people who inject drugs in Ukraine.
Sazonova Y; Kulchynska R; Sereda Y; Azarskova M; Novak Y; Saliuk T; Kornilova M; Liulchuk M; Vitek C; Dumchev K
PLoS One; 2020; 15(12):e0244572. PubMed ID: 33382768
[TBL] [Abstract][Full Text] [Related]
2. The role of access to integrated services at opioid agonist treatment sites in reaching 90-90-90 cascade in people who inject drugs in Ukraine: Country-level data.
Meteliuk A; Prokhorova T; Filippovych S; Ompad DC; Zaller N
Drug Alcohol Depend; 2020 Nov; 216():108216. PubMed ID: 32805547
[TBL] [Abstract][Full Text] [Related]
3. Population-level prevalence of detectable HIV viremia in people who inject drugs (PWID) in Ukraine: Implications for HIV treatment and case finding interventions.
Sazonova Y; Kulchynska R; Azarskova M; Liulchuk M; Salyuk T; Doan I; Barzilay E
PLoS One; 2023; 18(10):e0290661. PubMed ID: 37883454
[TBL] [Abstract][Full Text] [Related]
4. Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine.
Mazhnaya A; Marcus R; Bojko MJ; Zelenev A; Makarenko I; Pykalo I; Filippovych S; Dvoriak S; Altice FL
J Acquir Immune Defic Syndr; 2018 Nov; 79(3):288-295. PubMed ID: 30312275
[TBL] [Abstract][Full Text] [Related]
5. Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study.
Kiriazova T; Go VF; Hershow RB; Hamilton EL; Sarasvita R; Bui Q; Lancaster KE; Dumchev K; Hoffman IF; Miller WC; Latkin CA
Harm Reduct J; 2020 Oct; 17(1):69. PubMed ID: 32998731
[TBL] [Abstract][Full Text] [Related]
6. Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: a modelling study.
Tan J; Altice FL; Madden LM; Zelenev A
Lancet HIV; 2020 Feb; 7(2):e121-e128. PubMed ID: 31879250
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: implications for retention on opioid agonist therapy.
Kutsa O; Marcus R; Bojko MJ; Zelenev A; Mazhnaya A; Dvoriak S; Filippovych S; Altice FL
J Int AIDS Soc; 2016; 19(4 Suppl 3):20897. PubMed ID: 27435717
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus status awareness and test results confirmation among people who inject drugs in Ukraine.
Iakunchykova O; Meteliuk A; Zelenev A; Mazhnaya A; Tracy M; Altice FL
Int J Drug Policy; 2018 Jul; 57():11-17. PubMed ID: 29655101
[TBL] [Abstract][Full Text] [Related]
9. Has resourcing of non-governmental harm-reduction organizations in Ukraine improved HIV prevention and treatment outcomes for people who inject drugs? Findings from multiple bio-behavioural surveys.
Trickey A; Semchuk N; Saliuk T; Sazonova Y; Varetska O; Walker JG; Lim AG; Stone J; Vickerman P
J Int AIDS Soc; 2020 Aug; 23(8):e25608. PubMed ID: 32851812
[TBL] [Abstract][Full Text] [Related]
10. Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV?
Panagiotoglou D; Krebs E; Min JE; Olding M; Ahamad K; Ti L; Montaner JSG; Nosyk B
Int J Drug Policy; 2017 Sep; 47():169-176. PubMed ID: 28578865
[TBL] [Abstract][Full Text] [Related]
11. Operationalizing the HIV prevention cascade for PWID using the integrated bio-behavioural survey data from Ukraine.
Dumchev K; Sazonova Y; Smyrnov P; Cheshun O; Pashchuk O; Saliuk T; Varetska O
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25509. PubMed ID: 32602659
[TBL] [Abstract][Full Text] [Related]
12. Modelling integrated antiretroviral treatment and harm reduction services on HIV and overdose among people who inject drugs in Tijuana, Mexico.
Cepeda JA; Bórquez A; Magana C; Vo A; Rafful C; Rangel G; Medina-Mora ME; Strathdee S; Martin NK
J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25493. PubMed ID: 32562375
[TBL] [Abstract][Full Text] [Related]
13. Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
Makarenko I; Mazhnaya A; Polonsky M; Marcus R; Bojko MJ; Filippovych S; Springer S; Dvoriak S; Altice FL
Drug Alcohol Depend; 2016 Aug; 165():213-20. PubMed ID: 27370527
[TBL] [Abstract][Full Text] [Related]
14. HIV And HCV adherence and treatment outcomes among people who inject drugs receiving opioid agonist therapy.
J Minhas H; Akiyama MJ; Norton BL; Heo M; Arnsten JH; Litwin AH
AIDS Care; 2022 Oct; 34(10):1229-1233. PubMed ID: 34533062
[TBL] [Abstract][Full Text] [Related]
15. Stigma and quality of co-located care for HIV-positive people in addiction treatment in Ukraine: a cross-sectional study.
Sereda Y; Kiriazova T; Makarenko O; Carroll JJ; Rybak N; Chybisov A; Bendiks S; Idrisov B; Dutta A; Gillani FS; Samet JH; Flanigan T; Lunze K
J Int AIDS Soc; 2020 May; 23(5):e25492. PubMed ID: 32372534
[TBL] [Abstract][Full Text] [Related]
16. Modelling the impact and cost-effectiveness of non-governmental organizations on HIV and HCV transmission among people who inject drugs in Ukraine.
Stone J; Trickey A; Walker JG; Bivegete S; Semchuk N; Sazonova Y; Varetska O; Altice FL; Saliuk T; Vickerman P
J Int AIDS Soc; 2023 Apr; 26(4):e26073. PubMed ID: 37012669
[TBL] [Abstract][Full Text] [Related]
17. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
[TBL] [Abstract][Full Text] [Related]
18. Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study.
Cepeda JA; Eritsyan K; Vickerman P; Lyubimova A; Shegay M; Odinokova V; Beletsky L; Borquez A; Hickman M; Beyrer C; Martin NK
Lancet HIV; 2018 Oct; 5(10):e578-e587. PubMed ID: 30033374
[TBL] [Abstract][Full Text] [Related]
19. A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
Miller WC; Hoffman IF; Hanscom BS; Ha TV; Dumchev K; Djoerban Z; Rose SM; Latkin CA; Metzger DS; Lancaster KE; Go VF; Dvoriak S; Mollan KR; Reifeis SA; Piwowar-Manning EM; Richardson P; Hudgens MG; Hamilton EL; Sugarman J; Eshleman SH; Susami H; Chu VA; Djauzi S; Kiriazova T; Bui DD; Strathdee SA; Burns DN
Lancet; 2018 Sep; 392(10149):747-759. PubMed ID: 30191830
[TBL] [Abstract][Full Text] [Related]
20. Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
Makarenko I; Mazhnaya A; Marcus R; Bojko MJ; Madden L; Filippovich S; Dvoriak S; Altice FL
Int J Drug Policy; 2017 Jul; 45():56-63. PubMed ID: 28628853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]